Impact of Women's Home Environment on Use of the Dapivirine Vaginal Ring for HIV Prevention in Sub-Saharan Africa

AIDS Behav. 2021 Dec;25(12):3847-3857. doi: 10.1007/s10461-021-03311-y. Epub 2021 May 19.

Abstract

The monthly dapivirine vaginal ring has proven efficacious in reducing HIV incidence in two Phase 3 clinical trials. When considering the potential future availability of the ring to the public, key questions remain about the feasibility of integrating the ring as an HIV prevention intervention into women's lives. We conducted qualitative mapping interviews (n = 66) among women enrolled in MTN-025/HOPE, an open-label trial conducted in Malawi, South Africa, Uganda and Zimbabwe, to examine how home environments influenced use of the dapivirine vaginal ring. Most women had secure places to store their rings including wardrobes, suitcases, and bags. The primary concerns for ring storage were potential tampering from children or rodents. Household overcrowding limited the privacy some women had which made removal and insertion of vaginal rings challenging. Despite these challenges, ring storage, insertion, and removal was feasible across social and living contexts.

Keywords: HIV prevention; Home environment; Qualitative; Vaginal ring; Women.

Publication types

  • Clinical Trial

MeSH terms

  • Anti-HIV Agents* / therapeutic use
  • Contraceptive Devices, Female*
  • Female
  • HIV Infections* / drug therapy
  • HIV Infections* / epidemiology
  • HIV Infections* / prevention & control
  • Humans
  • Malawi / epidemiology
  • Pyrimidines

Substances

  • Anti-HIV Agents
  • Pyrimidines
  • Dapivirine